Smoking cessation and outcome after ischemic stroke or TIA
Katherine A Epstein, Catherine M Viscoli, J David Spence, Lawrence H Young, Silvio E Inzucchi, Mark Gorman, Brett Gerstenhaber, Peter D Guarino, Anand Dixit, Karen L Furie, Walter N Kernan
Neurology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2017
Awarded by National Institute of Neurological Disorders and Stroke (NINDS), NIH
Awarded by NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
This work (and the original IRIS trial) was supported by a grant (U01NS044876) from the National Institute of Neurological Disorders and Stroke (NINDS), NIH. Pioglitazone and placebo for the original IRIS trial were provided by Takeda Pharmaceuticals. The NINDS and Takeda Pharmaceuticals had no role in data collection, data analysis, data interpretation, or writing of this report.